Form 4: BIO-key CEO DePasquale Increases Stake via ESPP

BIO-key International CEO Michael W. DePasquale acquired 2,500 shares of common stock at $0.46 per share through the company's Employee Stock Purchase Plan.

Summary

• Michael W. DePasquale, CEO and Chairman of BIO-key International, Inc. (BKYI), acquired 2,500 shares of common stock.
• The transaction occurred on December 31, 2025, at a price of $0.46 per share.
• The shares were acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan (ESPP).
• This acquisition is exempt under SEC Rules 16b-3(d) and 16b-3(c).
• Following this transaction, Mr. DePasquale beneficially owns 105,275 shares of common stock.
• This beneficial ownership figure does not include options to purchase 232 shares or 9,167 shares issuable upon exercise of warrants.

Sentiment

Score: 7

Explanation: The acquisition of shares by the CEO is a positive signal of confidence, although the low share price could indicate underlying challenges. The transaction is part of an employee plan, which is a standard benefit.

Positives

• The CEO and Chairman, Michael W. DePasquale, increased his direct ownership in the company, signaling confidence in BIO-key's future prospects.
• The acquisition was made through an Employee Stock Purchase Plan, indicating participation in a broad-based employee benefit program.

Negatives

• The acquisition price of $0.46 per share is relatively low, which could reflect a low current market valuation for the company's stock.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The acquisition of 2,500 shares by CEO Michael W. DePasquale through the BIO-key International, Inc. 2021 Employee Stock Purchase Plan is a transaction between a related party (executive) and the company.

Stakeholder Impact

• Shareholders may view the CEO's increased stake as a positive sign of confidence, potentially boosting investor sentiment.
• Employees: The transaction through an ESPP highlights the availability of such plans, which can be a benefit for employees.

Key Dates

Recommendation

While the CEO's decision to increase his stake is a positive signal of confidence, a Form 4 filing alone provides limited information for a comprehensive investment recommendation. Investors should consider this insider buying in conjunction with the company's broader financial performance, strategic outlook, and market conditions before making a definitive investment decision. The low share price of the acquisition warrants further investigation into the company's valuation and prospects.

Keywords

BIO-key International, BKYI, Michael W. DePasquale, Insider Trading, Form 4, Stock Purchase, CEO, Employee Stock Purchase Plan, ESPP, Common Stock